{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T06:52:50Z","timestamp":1761893570568},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2002,6,1]],"date-time":"2002-06-01T00:00:00Z","timestamp":1022889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,6,1]],"date-time":"2002-06-01T00:00:00Z","timestamp":1022889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"published-print":{"date-parts":[[2002,6,1]]},"DOI":"10.1038\/sj.jhh.1001406","type":"journal-article","created":{"date-parts":[[2002,9,23]],"date-time":"2002-09-23T13:30:51Z","timestamp":1032787851000},"page":"379-383","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Clinical evidence of dose-dependent interaction between aspirin and angiotensin-converting enzyme inhibitors"],"prefix":"10.1038","volume":"16","author":[{"given":"E Z","family":"Fisman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Motro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Tenenbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2002,6,5]]},"reference":[{"key":"BF1001406_CR1","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1016\/S0735-1097(00)00637-9","volume":"35","author":"D Hall","year":"2000","unstructured":"Hall D . The aspirin-angiotensin-converting enzyme inhibitor tradeoff: to halve and halve not J Am Coll Cardiol 2000; 35: 1808\u20131812","journal-title":"J Am Coll Cardiol"},{"key":"BF1001406_CR2","doi-asserted-by":"publisher","first-page":"42S","DOI":"10.1016\/0002-9343(91)90485-G","volume":"90","author":"MC Houston","year":"1991","unstructured":"Houston MC . Nonsteroidal anti-inflammatory drugs and antihypertensives Am J Med 1991; 90: 42S\u20137S","journal-title":"Am J Med"},{"key":"BF1001406_CR3","doi-asserted-by":"publisher","first-page":"289","DOI":"10.7326\/0003-4819-121-4-199408150-00011","volume":"121","author":"AG Johnson","year":"1994","unstructured":"Johnson AG, Nguyen TV, Day RO . Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis Ann Intern Med 1994; 121: 289\u2013300","journal-title":"Ann Intern Med"},{"key":"BF1001406_CR4","doi-asserted-by":"publisher","first-page":"II4","DOI":"10.1161\/01.HYP.11.3_Pt_2.II4","volume":"11","author":"JA Oates","year":"1988","unstructured":"Oates JA . Antagonism of antihypertensive drug therapy by nonsteroidal anti-inflammatory drugs Hypertension 1988; 11: II4\u2013II6","journal-title":"Hypertension"},{"key":"BF1001406_CR5","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/0735-1097(92)90449-W","volume":"20","author":"D Hall","year":"1992","unstructured":"Hall D, Zeitler H, Rudolph W . Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure J Am Coll Cardiol 1992; 20: 1549\u20131555","journal-title":"J Am Coll Cardiol"},{"key":"BF1001406_CR6","doi-asserted-by":"publisher","first-page":"23A","DOI":"10.1016\/0735-1097(95)91553-A","volume":"25","author":"KN Nguyen","year":"1995","unstructured":"Nguyen KN, Aursnes I, Snappin S, Kjekshus J . Antagonism between enalapril and aspirin: subgroup analysis of the Cooperative New Scandinavian Enalapril Survival Study II (Consensus II) J Am Coll Cardiol 1995; 25: 23A (abstr)","journal-title":"J Am Coll Cardiol"},{"key":"BF1001406_CR7","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1016\/S0735-1097(99)00129-1","volume":"33","author":"J Leor","year":"1999","unstructured":"Leor J et al. Aspirin and mortality inpatients treated with angiotensin-converting enzyme inhibitors: a cohort study of 11,575patients with coronary artery disease J Am Coll Cardiol 1999; 33: 1920\u20131925","journal-title":"J Am Coll Cardiol"},{"key":"BF1001406_CR8","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/S0895-7061(99)00037-0","volume":"12","author":"JJ Nawarskas","year":"1999","unstructured":"Nawarskas JJ, Townsend RR, Cirigliano MD, Spinler SA . Effect of aspirin on blood pressure in hypertensivepatients taking enalapril or losartan Am J Hypertens 1999; 12: 784\u2013789","journal-title":"Am J Hypertens"},{"key":"BF1001406_CR9","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/j.1875-9114.1998.tb03933.x","volume":"18","author":"JJ Nawarskas","year":"1998","unstructured":"Nawarskas JJ, Spinler SA . Does aspirin interfere with the therapeutic efficacy of angiotensin-converting enzyme inhibitors in hypertension or congestive heart failure? Pharmacotherapy 1998; 18: 1041\u20131052","journal-title":"Pharmacotherapy"},{"key":"BF1001406_CR10","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/00005344-199402000-00010","volume":"23","author":"J van Wijngarden","year":"1994","unstructured":"van Wijngarden J et al. Effects of acetylsalicylic acid on peripheral haemodynamics inpatients with chronic heart failure treated with ACE inhibitors J Cardiovasc Pharmacol 1994; 23: 240\u2013245","journal-title":"J Cardiovasc Pharmacol"},{"key":"BF1001406_CR11","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1136\/hrt.73.3.227","volume":"73","author":"LHB Baur","year":"1995","unstructured":"Baur LHB et al. Combining salicylate and enalapril inpatients with coronary artery disease and heart failure Br Heart J 1995; 73: 227\u2013236","journal-title":"Br Heart J"},{"key":"BF1001406_CR12","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.7326\/0003-4819-117-3-234","volume":"117","author":"ZH Israili","year":"1992","unstructured":"Israili ZH, Dallas Hall W . Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology Ann Intern Med 1992; 117: 2324\u20132342","journal-title":"Ann Intern Med"},{"key":"BF1001406_CR13","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1001\/archinte.1989.00390120061012","volume":"149","author":"GR Gibson","year":"1989","unstructured":"Gibson GR . Enalapril-induced cough Arch Intern Med 1989; 149: 2701\u20132703","journal-title":"Arch Intern Med"},{"key":"BF1001406_CR14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.2165\/00002018-199615010-00006","volume":"15","author":"A Overlack","year":"1996","unstructured":"Overlack A . ACE inhibitor-induced cough and bronchospasm. Incidence, mechanisms and management Drug Saf 1996; 15: 72\u201378","journal-title":"Drug Saf"},{"key":"BF1001406_CR15","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0014-2999(79)90491-6","volume":"57","author":"R Greenberg","year":"1979","unstructured":"Greenberg R, Osman GH Jr, O'Keefe EH, Antonaccio MJ . The effects of captopril (SQ 14,225) on bradykinin-induced bronchoconstriction in the anesthetised guinea pig Eur J Pharmacol 1979; 57: 287\u2013294","journal-title":"Eur J Pharmacol"},{"key":"BF1001406_CR16","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/0002-9149(82)90351-4","volume":"49","author":"SL Swartz","year":"1982","unstructured":"Swartz SL, Williams GH . Angiotensin-converting enzyme inhibition and prostaglandins Am J Cardiol 1982; 49: 1405\u20131409","journal-title":"Am J Cardiol"},{"key":"BF1001406_CR17","first-page":"451","volume":"3","author":"NL Gilchrist","year":"1989","unstructured":"Gilchrist NL, Richards AM, March M, Nicholls MG . Effect of sulindac on, angiotensin-converting enzyme inhibitor-induced cough: randomised placebo-controlled double-blind cross-over study J Hum Hypertens 1989; 3: 451\u2013455","journal-title":"J Hum Hypertens"},{"key":"BF1001406_CR18","first-page":"645","volume":"5","author":"C Le Jeune","year":"1988","unstructured":"Le Jeune C et al. Cough provoked by angiotensin converting enzyme inhibitor. Effect of non-steroidal anti-inflammatory agents Rev Mal Respir 1988; 5: 645\u2013647","journal-title":"Rev Mal Respir"},{"key":"BF1001406_CR19","first-page":"122","volume":"43","author":"M Biour","year":"1988","unstructured":"Biour M, Le Jeune C, Hugues FC, Cheymol G . Diclofenac and cough induced by angiotensin converting enzyme inhibitors (letter) Therapie 1988; 43: 122\u2013123","journal-title":"Therapie"},{"key":"BF1001406_CR20","first-page":"161","volume":"225","author":"JR McEwan","year":"1990","unstructured":"McEwan JR, Choudry NB, Fuller RB . The effect of sulindac on the abnormal cough reflex associated with dry cough J Pharmacol Exp Ther 1990; 225: 161\u2013164","journal-title":"J Pharmacol Exp Ther"},{"key":"BF1001406_CR21","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/S0895-7061(00)00268-5","volume":"13","author":"A Tenebaum","year":"2000","unstructured":"Tenebaum A et al. Intermediate but not low doses of aspirin can suppress angiotensin-converting enzyme inhibitor-induced cough Am J Hypertens 2000; 13: 776\u2013782","journal-title":"Am J Hypertens"},{"key":"BF1001406_CR22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0140-6736(96)12045-6","volume":"350","author":"PL Malini","year":"1997","unstructured":"Malini PL et al. Thromboxane antagonism and cough induced by angiotensin-converting-enzyme-inhibitors Lancet 1997; 350: 15\u201318","journal-title":"Lancet"},{"key":"BF1001406_CR23","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1161\/01.CIR.88.5.2460","volume":"88","author":"D Perloff","year":"1993","unstructured":"Perloff D et al. Human blood pressure determinations by sphygmomanometry Circulation 1993; 88: 2460\u20132470","journal-title":"Circulation"},{"key":"BF1001406_CR24","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0140-6736(94)92405-8","volume":"343","author":"E Anggard","year":"1994","unstructured":"Anggard E . Nitric oxid: mediator, murderer, and medicine Lancet 1994; 343: 1199\u20131206","journal-title":"Lancet"},{"key":"BF1001406_CR25","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1159\/000006837","volume":"90","author":"A Tenenbaum","year":"1998","unstructured":"Tenenbaum A, Fisman EZ, Motro M . L-Arginine: rediscovery in progress Cardiology 1998; 90: 153\u2013159","journal-title":"Cardiology"},{"key":"BF1001406_CR26","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/S0024-3205(97)00124-0","volume":"60","author":"K Umemura","year":"1997","unstructured":"Umemura K, Nakashima M, Saruta T . Thromboxane A2 synthetase inhibition supresses cough induced by angiotensin converting enzyme inhibitors Life Sci 1997; 60: 1583\u20131588","journal-title":"Life Sci"},{"key":"BF1001406_CR27","doi-asserted-by":"publisher","first-page":"247S","DOI":"10.1378\/chest.108.4_Supplement.247S","volume":"108","author":"J Hirsch","year":"1995","unstructured":"Hirsch J et al. Aspirin and other platelet-active drugs Chest 1995; 108: 247S\u2013254S","journal-title":"Chest"},{"key":"BF1001406_CR28","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1073\/pnas.72.8.3073","volume":"72","author":"GJ Roth","year":"1975","unstructured":"Roth GJ, Stanford N, Majerus PW . Acetylation of prostaglandin synthase by aspirin Proc Natl Acad Sci USA 1975; 72: 3073\u20133077","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF1001406_CR29","first-page":"293","volume":"30","author":"S Moncada","year":"1978","unstructured":"Moncada S, Vane JR . Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane-A2 and prostacyclin Pharmacol Rev 1978; 30: 293\u2013331","journal-title":"Pharmacol Rev"},{"key":"BF1001406_CR30","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/0090-6980(80)90042-8","volume":"20","author":"G Rossoni","year":"1980","unstructured":"Rossoni G et al. Bronchoconstriction by histamine and bradykinin in guinea pigs: relationship to thromboxane-A2 generation and the effect of aspirin Prostaglandins 1980; 20: 547\u2013557","journal-title":"Prostaglandins"},{"key":"BF1001406_CR31","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1001\/archinte.160.10.1409","volume":"160","author":"T Stys","year":"2000","unstructured":"Stys T, Lawson WE, Smaldone GC, Stys A . Does aspirin attenuate the beneficial effects of angiotensin-converting enzyme inhibition in heart failure? Arch Intern Med 2000; 160: 1409\u20131413","journal-title":"Arch Intern Med"},{"key":"BF1001406_CR32","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1097\/00041552-200109000-00012","volume":"10","author":"JG Cleland","year":"2001","unstructured":"Cleland JG, John J, Houghton T . Does aspirin attenuate the effect of angiotensin-converting enzyme inhibitors in hypertension or heart failure? Curr Opin Nephrol Hypertens 2001; 10: 625\u2013631","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"BF1001406_CR33","first-page":"661","volume":"283","author":"DR Allan","year":"1997","unstructured":"Allan DR, Hui KY, Coletti C, Hollenberg NK . Renin vs. angiotensin converting enzyme inhibition in the rat: consequences for plasma and renal tissue angiotensin J Pharmacol Exp Ther 1997; 283: 661\u2013665","journal-title":"J Pharmacol Exp Ther"},{"key":"BF1001406_CR34","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1161\/01.STR.25.12.2331","volume":"25","author":"CM Helgason","year":"1994","unstructured":"Helgason CM et al. Development of aspirin resistance in persons with ischemic stroke Stroke 1994; 25: 2331\u20132336","journal-title":"Stroke"},{"key":"BF1001406_CR35","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","volume":"351","author":"L Hansson","year":"1998","unstructured":"Hansson L et al. Effects of intensive blood-pressure lowering and low-dose aspirin inpatients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group Lancet 1998; 351: 1755\u20131762","journal-title":"Lancet"},{"key":"BF1001406_CR36","doi-asserted-by":"crossref","unstructured":"The RISC group. Risk of myocardial infarction and death during tratment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease Lancet 1990; 336: S27\u2013S30","DOI":"10.1016\/0140-6736(90)92336-G"},{"key":"BF1001406_CR37","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1056\/NEJM198308183090703","volume":"309","author":"HD Lewis","year":"1983","unstructured":"Lewis HD et al. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina: results of a Veterans Administration Cooperative Study N Engl J Med 1983; 309: 396\u2013403","journal-title":"N Engl J Med"},{"key":"BF1001406_CR38","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1056\/NEJM198511283132201","volume":"313","author":"JA Cairns","year":"1985","unstructured":"Cairns JA et al. Aspirin, silfinpyrazone, or both in unstable angina N Engl J Med 1985; 313: 1369\u20131375","journal-title":"N Engl J Med"},{"key":"BF1001406_CR39","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1136\/hrt.74.3.215","volume":"74","author":"JG Cleland","year":"1995","unstructured":"Cleland JG et al. Is aspirin safe forpatients with heart failure? Br Heart J 1995; 74: 215\u2013219","journal-title":"Br Heart J"},{"key":"BF1001406_CR40","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/00005344-199402000-00010","volume":"23","author":"J van Wijngarden","year":"1994","unstructured":"van Wijngarden J et al. Effects of acetylsalicylic acid on peripheral haemodynamics inpatients with chronic heart failure treated with ACE inhibitors J Cardiovasc Pharmacol 1994; 23: 240\u2013245","journal-title":"J Cardiovasc Pharmacol"},{"key":"BF1001406_CR41","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1001\/jama.286.10.1187","volume":"286","author":"PA Gum","year":"2001","unstructured":"Gum PA et al. Aspirin use and all-cause mortality amongpatients being evaluated for known or suspected coronary artery disease: A propensity analysis JAMA 2001; 286: 1187\u20131194","journal-title":"JAMA"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1001406.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1001406","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1001406.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T12:48:12Z","timestamp":1704286092000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1001406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6,1]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2002,6,1]]}},"alternative-id":["BF1001406"],"URL":"https:\/\/doi.org\/10.1038\/sj.jhh.1001406","relation":{},"ISSN":["0950-9240","1476-5527"],"issn-type":[{"value":"0950-9240","type":"print"},{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,6,1]]},"assertion":[{"value":"5 June 2002","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}